|  |  | Control | Non-tailored | tailored | |||
---|---|---|---|---|---|---|---|---|
 |  |  | n | % | n | % | n | % |
ITT Sample | AGE | 50–54 | 348 | 30.7% | 330 | 29.0% | 331 | 29.1% |
55–59 | 302 | 26.6% | 298 | 26.2% | 315 | 27.7% | ||
60–64 | 266 | 23.4% | 296 | 26.1% | 275 | 24.2% | ||
65–69 | 126 | 11.1% | 123 | 10.8% | 142 | 12.5% | ||
70–74 | 93 | 8.2% | 89 | 7.8% | 74 | 6.5% | ||
SEX | Male | 557 | 49.1% | 556 | 48.9% | 559 | 49.2% | |
Female | 578 | 50.9% | 580 | 51.1% | 578 | 50.8% | ||
SEIFA* | SEI_AD <5 | 173 | 15.2% | 173 | 15.2% | 190 | 16.7% | |
SEI_AD >5 | 962 | 84.8% | 963 | 84.8% | 947 | 83.3% | ||
STATE | NSW | 219 | 19.3% | 220 | 19.4% | 220 | 19.3% | |
QLD | 214 | 18.9% | 214 | 18.8% | 215 | 18.9% | ||
SA | 242 | 21.3% | 242 | 21.3% | 241 | 21.2% | ||
VIC | 210 | 18.5% | 209 | 18.4% | 210 | 18.5% | ||
WA | 250 | 22.0% | 251 | 22.1% | 251 | 22.1% | ||
Per Protocol Sample | AGE | 50–54 | 238 | 28.9% | 207 | 28.9% | 205 | 28.0% |
55–59 | 220 | 26.7% | 187 | 26.1% | 200 | 27.4% | ||
60–64 | 195 | 23.7% | 177 | 24.7% | 184 | 25.2% | ||
65–69 | 100 | 12.2% | 85 | 11.9% | 90 | 12.3% | ||
70–74 | 70 | 8.5% | 60 | 8.4% | 52 | 7.1% | ||
SEX | Male | 413 | 50.2% | 368 | 51.4% | 371 | 50.8% | |
Female | 410 | 49.8% | 348 | 48.6% | 360 | 49.2% | ||
SEIFA* | SEI_AD <5 | 128 | 15.6% | 97 | 13.5% | 111 | 15.2% | |
SEI_AD >5 | 695 | 84.4% | 619 | 86.5% | 620 | 84.8% | ||
STATE | NSW | 154 | 18.7% | 128 | 17.9% | 123 | 16.8% | |
QLD | 162 | 19.7% | 148 | 20.7% | 139 | 19.0% | ||
SA | 178 | 21.6% | 151 | 21.1% | 162 | 22.2% | ||
VIC | 151 | 18.3% | 129 | 18.0% | 128 | 17.5% | ||
WA | 178 | 21.6% | 160 | 22.3% | 179 | 24.5% |